1. Home
  2. TRI vs NTRA Comparison

TRI vs NTRA Comparison

Compare TRI & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thomson Reuters Corp

TRI

Thomson Reuters Corp

N/A

Current Price

$105.71

Market Cap

46.4B

Sector

N/A

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$331.64

Market Cap

45.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRI
NTRA
Founded
1851
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4B
45.3B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
TRI
NTRA
Price
$105.71
$331.64
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$154.58
$259.07
AVG Volume (30 Days)
2.3M
1.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.62%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
$8.90
$18.08
Revenue Next Year
$7.89
$19.65
P/E Ratio
$25.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$76.28
$157.43
52 Week High
$180.00
$333.56

Technical Indicators

Market Signals
Indicator
TRI
NTRA
Relative Strength Index (RSI) 57.24 71.73
Support Level $81.19 $187.64
Resistance Level $113.40 N/A
Average True Range (ATR) 5.45 10.88
MACD -0.23 2.40
Stochastic Oscillator 53.49 96.11

Price Performance

Historical Comparison
TRI
NTRA

About TRI Thomson Reuters Corp

Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: